Tennessee taps Fishers company for COVID vaccine pilot

Fishers-based Knowledge Services has been selected by the Tennessee Department of Health to help with Pfizer's COVID-19 vaccine pilot program.

Enrollment for COVID-19 vaccine trial begins at IU School of Medicine

The Indiana University School of Medicine in Indianapolis has begun enrolling volunteers for a late-stage clinical study of an investigational COVID-19 vaccine from AstraZeneca plc (Nasdaq: AZN).

Lilly antibody treatment lands FDA Emergency Use Authorization

The U.S. Food and Drug Administration has granted an Emergency Use Authorization for a COVID-19 antibody therapy developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY).

Lilly reaches agreement with government for COVID treatment

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has reached an initial agreement with the U.S. government to supply 300,000 vials of its investigational antibody treatment for COVID-19.

Applications open for Indy hospitality grant program

The city of Indianapolis has begun accepting applications for a grant program designed to help local restaurants, bars, and entertainment venues

Lilly details COVID treatment manufacturing partnership

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Amgen Inc. (Nasdaq: AMGN) are collaborating on the manufacturing of potential COVID-19 therapies.